Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.
Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N; JONIE STUDY GROUP. Hayashi M, et al. Anticancer Res. 2019 Aug;39(8):4305-4314. doi: 10.21873/anticanres.13596. Anticancer Res. 2019. PMID: 31366522 Clinical Trial.
Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study).
Hasegawa Y, Tanino H, Horiguchi J, Miura D, Ishikawa T, Hayashi M, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Akazawa K, Kohno N; JONIE Study Group. Hasegawa Y, et al. Among authors: hayashi m. PLoS One. 2015 Dec 3;10(12):e0143643. doi: 10.1371/journal.pone.0143643. eCollection 2015. PLoS One. 2015. PMID: 26633806 Free PMC article. Clinical Trial.
A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study.
Narui K, Miura D, Hasegawa Y, Tachibana A, Horiguchi J, Hayashi M, Miyashita M, Kubota T, Suzuki M, Yamada K, Yamada A, Akazawa K, Kohno N, Ishikawa T. Narui K, et al. Among authors: hayashi m. Clin Breast Cancer. 2022 Dec;22(8):e881-e891. doi: 10.1016/j.clbc.2022.08.007. Epub 2022 Aug 22. Clin Breast Cancer. 2022. PMID: 36151017 Clinical Trial.
PET/CT supports breast cancer diagnosis and treatment.
Hayashi M, Murakami K, Oyama T, Domeki Y, Hagiwara S, Katsumata D, Sunagawa M. Hayashi M, et al. Breast Cancer. 2008;15(3):224-30. doi: 10.1007/s12282-008-0051-2. Breast Cancer. 2008. PMID: 18465196
[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study].
Anan K, Tanaka M, Yoshinaga Y, Maeda S, Yamaguchi Y, Hayashi M, Tanaka M, Kamata Y, Mashino K, Yamamoto Y, Nishimura J, Matsuo S, Toyoshima S, Tamura K, Mitsuyama S; Kuyshu Brest Cancer Study Group. Anan K, et al. Among authors: hayashi m. Gan To Kagaku Ryoho. 2015 Jan;42(1):45-50. Gan To Kagaku Ryoho. 2015. PMID: 25596678 Japanese.
6,978 results